» Articles » PMID: 28663341

Determinants of Hospital Death in Haematological Cancers: Findings from a Qualitative Study

Overview
Date 2017 Jul 1
PMID 28663341
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Current UK health policy promotes enabling people to die in a place they choose, which for most is home. Despite this, patients with haematological malignancies (leukaemias, lymphomas and myeloma) are more likely to die in hospital than those with other cancers, and this is often considered a reflection of poor quality end-of-life care. This study aimed to explore the experiences of clinicians and relatives to determine why hospital deaths predominate in these diseases.

Methods: The study was set within the Haematological Malignancy Research Network (HMRN-www.hmrn.org), an ongoing population-based cohort that provides infrastructure for evidence-based research. Qualitative interviews were conducted with clinical staff in haematology, palliative care and general practice (n=45) and relatives of deceased HMRN patients (n=10). Data were analysed for thematic content and coding and classification was inductive. Interpretation involved seeking meaning, salience and connections within the data.

Results: Five themes were identified relating to: the characteristics and trajectory of haematological cancers, a mismatch between the expectations and reality of home death, preference for hospital death, barriers to home/hospice death and suggested changes to practice to support non-hospital death, when preferred.

Conclusions: Hospital deaths were largely determined by the characteristics of haematological malignancies, which included uncertain trajectories, indistinct transitions and difficulties predicting prognosis and identifying if or when to withdraw treatment. Advance planning (where possible) and better communication between primary and secondary care may facilitate non-hospital death.

Citing Articles

Challenges in hospice and end-of-life care in the transfusion-dependent patient.

Rodenbach R, Caprio T, Loh K Hematology Am Soc Hematol Educ Program. 2024; 2024(1):340-347.

PMID: 39644067 PMC: 11665515. DOI: 10.1182/hematology.2024000560.


Perspectives on Transfusions for Hospice Patients With Blood Cancers: A Survey of Hospice Providers.

Knight H, Brennan C, Hurley S, Tidswell A, Aldridge M, Johnson K J Pain Symptom Manage. 2023; 67(1):1-9.

PMID: 37777022 PMC: 10873003. DOI: 10.1016/j.jpainsymman.2023.09.024.


Trends in Hospital Admissions Due to Neoplasms in England and Wales between 1999 and 2019: An Ecological Study.

Naser A, Alwafi H, Hemmo S, Alrawashdeh H, Alqahtani J, Alghamdi S Int J Environ Res Public Health. 2022; 19(13).

PMID: 35805710 PMC: 9265694. DOI: 10.3390/ijerph19138054.


Treatment decision making (TDM): a qualitative study exploring the perspectives of patients with chronic haematological cancers.

McCaughan D, Roman E, Smith A, Patmore R, Howell D BMJ Open. 2022; 12(3):e050816.

PMID: 35351694 PMC: 8966575. DOI: 10.1136/bmjopen-2021-050816.


Goal of a "Good Death" in End-of-Life Care for Patients with Hematologic Malignancies-Are We Close?.

Kuczmarski T, Odejide O Curr Hematol Malig Rep. 2021; 16(2):117-125.

PMID: 33864180 PMC: 8409152. DOI: 10.1007/s11899-021-00629-1.


References
1.
Wright B, Forbes K . Haematologists' perceptions of palliative care and specialist palliative care referral: a qualitative study. BMJ Support Palliat Care. 2014; 7(1):39-45. DOI: 10.1136/bmjspcare-2014-000689. View

2.
Ho T, Barbera L, Saskin R, Lu H, Neville B, Earle C . Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol. 2011; 29(12):1587-91. PMC: 3082976. DOI: 10.1200/JCO.2010.31.9897. View

3.
LeBlanc T, Smith J, Currow D . Symptom burden of haematological malignancies as death approaches in a community palliative care service: a retrospective cohort study of a consecutive case series. Lancet Haematol. 2015; 2(8):e334-8. DOI: 10.1016/S2352-3026(15)00111-8. View

4.
Smith A, Roman E, Howell D, Jones R, Patmore R, Jack A . The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research. Br J Haematol. 2009; 148(5):739-53. PMC: 3066245. DOI: 10.1111/j.1365-2141.2009.08010.x. View

5.
El-Jawahri A, Abel G, Steensma D, LeBlanc T, Fathi A, Graubert T . Health care utilization and end-of-life care for older patients with acute myeloid leukemia. Cancer. 2015; 121(16):2840-8. PMC: 4418225. DOI: 10.1002/cncr.29430. View